201 related articles for article (PubMed ID: 34331562)
21. POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.
Dispenzieri A
Am J Hematol; 2019 Jul; 94(7):812-827. PubMed ID: 31012139
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of novel agents in patients with nephropathy associated with POEMS syndrome.
Cheng S; Huang L; Fan W; Liang D; Zhu X; Jiang S; Ge Y
Int Urol Nephrol; 2022 Sep; 54(9):2317-2325. PubMed ID: 35133575
[TBL] [Abstract][Full Text] [Related]
23. Update on the Diagnosis and Treatment of POEMS (Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes) Syndrome: A Review.
Khouri J; Nakashima M; Wong S
JAMA Oncol; 2021 Sep; 7(9):1383-1391. PubMed ID: 34081097
[TBL] [Abstract][Full Text] [Related]
24. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
[TBL] [Abstract][Full Text] [Related]
25. Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial.
Katayama K; Misawa S; Sato Y; Sobue G; Yabe I; Watanabe O; Nishizawa M; Kusunoki S; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
BMJ Open; 2015 Jan; 5(1):e007330. PubMed ID: 25573527
[TBL] [Abstract][Full Text] [Related]
26. POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience.
Thoennissen GB; Thoennissen NH; Fritz F; Hilbig A; Kerkhoff A; Liersch R; Krug U; Koschmieder S; Müller-Tidow C; Mesters R; Kropff M; Berdel WE
Ann Hematol; 2012 Sep; 91(9):1419-25. PubMed ID: 22543828
[TBL] [Abstract][Full Text] [Related]
27. A Multicenter Analysis of Clinical Features and Long-Term Outcomes of POEMS Syndrome in Korea.
Kook HW; Jang JE; Min CK; Yoon DH; Kim K; Bang SM; Park Y; Lee JH; Yoon SS; Kim JS
J Korean Med Sci; 2024 Jan; 39(2):e5. PubMed ID: 38225781
[TBL] [Abstract][Full Text] [Related]
28. Bortezomib: a new therapeutic option for POEMS syndrome.
Kaygusuz I; Tezcan H; Cetiner M; Kocakaya O; Uzay A; Bayik M
Eur J Haematol; 2010 Feb; 84(2):175-7. PubMed ID: 19732138
[TBL] [Abstract][Full Text] [Related]
29. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
Yang H; Huang X; Cai Q; Wang C; Cao X; Zhou D; Li J
Orphanet J Rare Dis; 2016 Jun; 11(1):80. PubMed ID: 27317315
[TBL] [Abstract][Full Text] [Related]
30. POEMS Syndrome: Diagnosis and Investigative Work-up.
Dispenzieri A; Kourelis T; Buadi F
Hematol Oncol Clin North Am; 2018 Feb; 32(1):119-139. PubMed ID: 29157614
[TBL] [Abstract][Full Text] [Related]
31. POEMS Syndrome Showing Left Ventricular Dysfunction and Extracellular Edema Assessed by Cardiac Magnetic Resonance Imaging.
Takahashi Y; Iwano H; Nakano I; Fukushima A; Naya M; Shimizu A; Matsuno Y; Oyama-Manabe N; Anzai T
Intern Med; 2019 Sep; 58(17):2539-2543. PubMed ID: 31118405
[TBL] [Abstract][Full Text] [Related]
32. Neurologic improvement after peripheral blood stem cell transplantation in POEMS syndrome.
Kuwabara S; Misawa S; Kanai K; Suzuki Y; Kikkawa Y; Sawai S; Hattori T; Nishimura M; Nakaseko C
Neurology; 2008 Nov; 71(21):1691-5. PubMed ID: 18832140
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of newly diagnosed POEMS syndrome with reduced-dose bortezomib based regimen.
He H; Fu W; Du J; Jiang H; Hou J
Br J Haematol; 2018 Apr; 181(1):126-128. PubMed ID: 28146276
[No Abstract] [Full Text] [Related]
34. Endocrine Evaluation in POEMS Syndrome: A Cohort Study.
Yang H; Zhao H; Gao X; Huang X; Cao X; Zhou D; Xia W; Li J
Front Endocrinol (Lausanne); 2020; 11():536241. PubMed ID: 33193075
[TBL] [Abstract][Full Text] [Related]
35. Skin manifestations and vascular endothelial growth factor levels in POEMS syndrome: impact of autologous hematopoietic stem cell transplantation.
Barete S; Mouawad R; Choquet S; Viala K; Leblond V; Musset L; Amoura Z; Khayat D; Francès C
Arch Dermatol; 2010 Jun; 146(6):615-23. PubMed ID: 20566924
[TBL] [Abstract][Full Text] [Related]
36. Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report.
Paranavitane S; Gooneratne L; Chang T
J Med Case Rep; 2019 Dec; 13(1):384. PubMed ID: 31878962
[TBL] [Abstract][Full Text] [Related]
37. Renal impairment in patients with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes syndrome: incidence, treatment and outcome.
Ye W; Wang C; Cai QQ; Cai H; Duan MH; Li H; Cao XX; Zhou DB; Li J
Nephrol Dial Transplant; 2016 Feb; 31(2):275-83. PubMed ID: 26130736
[TBL] [Abstract][Full Text] [Related]
38. Correlation of changes in serum level of VEGF and peripapillary retinal thickness in patients with POEMS syndrome.
Yokouchi H; Baba T; Misawa S; Oshitari T; Kuwabara S; Yamamoto S
Br J Ophthalmol; 2020 Jan; 104(1):33-38. PubMed ID: 30914422
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of low-dose lenalidomide plus dexamethasone in patients with relapsed or refractory POEMS syndrome.
Cai QQ; Wang C; Cao XX; Cai H; Zhou DB; Li J
Eur J Haematol; 2015 Oct; 95(4):325-30. PubMed ID: 25401269
[TBL] [Abstract][Full Text] [Related]
40. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
Miralles GD; O'Fallon JR; Talley NJ
N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
